Pathogenic

BRCA1 BRCA2 biomarker gene mutation prostate cancer screening treatment strategies

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Nov 2021
Historique:
received: 03 09 2021
revised: 25 10 2021
accepted: 28 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Studies have demonstrated that men with Prostate Cancer (PCa) harboring

Identifiants

pubmed: 34830851
pii: cancers13225697
doi: 10.3390/cancers13225697
pmc: PMC8616097
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Wellcome Trust
ID : Unknown
Pays : United Kingdom

Références

Cancer Discov. 2018 Apr;8(4):444-457
pubmed: 29367197
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur Urol. 2020 Jan;77(1):24-35
pubmed: 31495749
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
J Urol. 2019 Aug;202(2):223-230
pubmed: 30730411
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
Br J Cancer. 2010 Sep 7;103(6):918-24
pubmed: 20736950
BJU Int. 2012 Mar;109(5):713-9
pubmed: 21756279
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
J Clin Oncol. 2018 Apr 1;36(10):991-999
pubmed: 29261439
Eur Urol. 2018 Aug;74(2):218-225
pubmed: 29439820
Adv Exp Med Biol. 2019;1210:87-110
pubmed: 31900906
N Engl J Med. 2020 Dec 10;383(24):2345-2357
pubmed: 32955174
Hum Mutat. 2012 Jan;33(1):2-7
pubmed: 21990146
Eur Urol. 2018 May;73(5):687-693
pubmed: 29429804
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Br J Cancer. 2021 Feb;124(3):552-563
pubmed: 33106584
Am Soc Clin Oncol Educ Book. 2019 Jan;39:79-86
pubmed: 31099688
J Med Genet. 2016 Jan;53(1):15-23
pubmed: 26187060
Lancet Oncol. 2015 Feb;16(2):152-60
pubmed: 25601341
Oncotarget. 2018 May 4;9(34):23661-23669
pubmed: 29805764
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Lancet. 1994 Mar 19;343(8899):692-5
pubmed: 7907678
Nat Rev Urol. 2019 May;16(5):281-290
pubmed: 30808988
J Med Genet. 2021 Nov;58(11):752-759
pubmed: 32963034
Trans Am Clin Climatol Assoc. 2017;128:14-23
pubmed: 28790484
J Oncol Pract. 2018 Jan;14(1):e23-e33
pubmed: 29194001
J Med Genet. 2002 Jul;39(7):457-62
pubmed: 12114473
Ann Intern Med. 2013 May 21;158(10):761-769
pubmed: 23567643
JAMA Oncol. 2015 Dec;1(9):1225-6
pubmed: 26426337
JCO Oncol Pract. 2020 Dec;16(12):811-819
pubmed: 32986533
Cancer. 2020 Jul 1;126(13):2980-2985
pubmed: 32315455
Sci Rep. 2020 May 6;10(1):7669
pubmed: 32376921
Eur J Cancer. 2021 Mar;146:30-47
pubmed: 33578357
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Nat Clin Pract Urol. 2009 Feb;6(2):87-95
pubmed: 19198622
CA Cancer J Clin. 2016 Jul;66(4):290-308
pubmed: 26910411
Ann Oncol. 2020 Sep;31(9):1119-1134
pubmed: 32593798
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Am J Hum Genet. 2001 Feb;68(2):410-9
pubmed: 11170890
Breast Cancer Res. 2012 Nov 13;14(6):115
pubmed: 23146216
BJU Int. 2019 May;123(5):769-776
pubmed: 30281887
Clin Cancer Res. 2010 Apr 1;16(7):2115-21
pubmed: 20215531
Cancer Sci. 2004 Nov;95(11):866-71
pubmed: 15546503
Target Oncol. 2020 Dec;15(6):709-722
pubmed: 33044685
N Engl J Med. 2019 Jul 4;381(1):13-24
pubmed: 31150574
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436
pubmed: 31061129
J Urol. 2015 Jan;193(1):75-9
pubmed: 25066872
CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40
pubmed: 4625049
N Engl J Med. 2014 Jul 31;371(5):424-33
pubmed: 24881730
Prostate. 2019 Jun;79(8):880-895
pubmed: 30900310
Rev Urol. 2008 Spring;10(2):111-9
pubmed: 18660852
JAMA Oncol. 2018 Jun 1;4(6):868-870
pubmed: 29242909
MMWR Morb Mortal Wkly Rep. 2020 Oct 16;69(41):1473-1480
pubmed: 33056955
Hum Mutat. 2018 May;39(5):593-620
pubmed: 29446198
Arch Ital Urol Androl. 2009 Dec;81(4):195-8
pubmed: 20608139
Scand J Urol. 2020 Apr;54(2):115-121
pubmed: 32266854
PLoS One. 2018 Jul 24;13(7):e0201086
pubmed: 30040829
J Urol. 1998 Aug;160(2):437-42
pubmed: 9679893
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Clin Cancer Res. 2004 May 1;10(9):2918-21
pubmed: 15131025
Diagnostics (Basel). 2021 Feb 19;11(2):
pubmed: 33669657
J Clin Oncol. 2020 Aug 20;38(24):2798-2811
pubmed: 32516092
Oncotarget. 2020 Jan 28;11(4):440-442
pubmed: 32064047
JAMA Oncol. 2021 Jan 1;7(1):107-110
pubmed: 33151258
Clin Genitourin Cancer. 2019 Aug;17(4):275-282.e1
pubmed: 31171481
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
Asian J Androl. 2012 May;14(3):409-14
pubmed: 22522501
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Cancer. 2017 Sep 15;123(18):3532-3539
pubmed: 28608931
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Eur Urol. 2015 Mar;67(3):496-503
pubmed: 25154392
Cancer. 1974 Oct;34(4):1102-7
pubmed: 4420271
Br J Cancer. 2012 May 8;106(10):1697-701
pubmed: 22516946
Curr Opin Obstet Gynecol. 2010 Feb;22(1):72-8
pubmed: 19841585
N Engl J Med. 2019 Mar 28;380(13):1235-1246
pubmed: 30763142
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):891-7
pubmed: 23515145
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
pubmed: 12237281
Trends Genet. 2012 Apr;28(4):155-63
pubmed: 22342180
J Mol Med (Berl). 1997 Oct;75(10):758-61
pubmed: 9383000
J Clin Oncol. 2020 Nov 10;38(32):3763-3772
pubmed: 32795228
Lancet Oncol. 2017 Sep;18(9):1274-1284
pubmed: 28754483
Cancer. 2015 Jan 15;121(2):269-75
pubmed: 25224030
Cancer Prev Res (Phila). 2011 Jul;4(7):1002-10
pubmed: 21733824
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
Br J Cancer. 2011 Oct 11;105(8):1230-4
pubmed: 21952622
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Breast Cancer Res. 2004;6(4):R284-90
pubmed: 15217494
Nat Rev Urol. 2014 Jan;11(1):18-31
pubmed: 24296704
J Oncol. 2020 Sep 7;2020:4986365
pubmed: 32963528

Auteurs

Ciara S McNevin (CS)

Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 W9RT Dublin, Ireland.
Department of Medical Oncology, St. James Hospital, D08 NHY1 Dublin, Ireland.

Karen Cadoo (K)

Department of Medical Oncology, St. James Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, Trinity Translational Medicine Institute, St. James Hospital, D08 W9RT Dublin, Ireland.

Anne-Marie Baird (AM)

School of Medicine, Trinity Translational Medicine Institute, St. James Hospital, D08 W9RT Dublin, Ireland.

Pierre Murchan (P)

Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 W9RT Dublin, Ireland.
Science Foundation Ireland Centre for Research Training in Genomics Data Science, School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, H91 TK33 Galway, Ireland.

Orla Sheils (O)

School of Medicine, Trinity Translational Medicine Institute, St. James Hospital, D08 W9RT Dublin, Ireland.

Ray McDermott (R)

Department of Medical Oncology, Tallaght University Hospital, D24 NR0A Dublin, Ireland.
Department of Medical Oncology, St. Vincent's University Hospital, D04 YN26 Dublin, Ireland.

Stephen Finn (S)

Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 W9RT Dublin, Ireland.
Department of Medical Oncology, St. James Hospital, D08 NHY1 Dublin, Ireland.

Classifications MeSH